title: [Hairy cell leukemia].
abstract: Hairy cell leukemia was initially described as a distinct entity in 1958. It is rare B-cell malignancy characterized by an indolent course. Advances in the treatment and understanding of the biology of hairy cell leukemia have made the disease exquisitely amenable to treatment. This review summarizes the present understanding of hairy cell leukemia with a particular focus on the development of novel and targeted approaches to treatment.
authors: Medizinische Klinik V, Universitätsklinikum Heidelberg, Heidelberg, Deutschland.
authors: S
authors: S
authors: Dietrich
authors: M
authors: M
authors: Andrulis
authors: T
authors: T
authors: Zenz
mesh_terms: D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D005819:Genetic Markers / Q000235:genetics*; D020022:Genetic Predisposition to Disease / Q000235:genetics; D006801:Humans; D007943:Leukemia, Hairy Cell / Q000175:diagnosis* / Q000235:genetics / Q000628:therapy*; D058990:Molecular Targeted Therapy / Q000379:methods*
chemical_list: D000911:Antibodies, Monoclonal; D000970:Antineoplastic Agents; D005819:Genetic Markers